CASTLE BIOSCIENCES INC (CSTL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue TTM

0 150M 300M 450M Q3 '21: 86.3M Q4 '21: 94.1M Q1 '22: 98.1M Q2 '22: 110.2M Q3 '22: 123.7M Q4 '22: 137M Q1 '23: 152.2M Q2 '23: 167.5M Q3 '23: 192M Q4 '23: 219.8M Q1 '24: 250.7M Q2 '24: 287.6M Q3 '24: 311.9M Q4 '24: 332.1M Q1 '25: 347.1M Q2 '25: 346.3M Q3 '25: 343.5M Q4 '25: 344.2M Q1 '26: 339.9M Q2 '26: 357.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 20M 40M 60M Q4 '18: 17.5M Q1 '19: 22.2M Q2 '19: 28.3M Q3 '19: 39M Q4 '19: 44.6M Q1 '20: 52.5M Q2 '20: 54.3M Q3 '20: 54M Q4 '20: 53M Q1 '21: 57.7M Q1 '19 Q3 '19 Q1 '20 Q3 '20 Q1 '21

Operating Income TTM

-105M -70M -35M 0 35M 70M 105M Q3 '21: -27.9M Q4 '21: -40.1M Q1 '22: -60.3M Q2 '22: -55.5M Q3 '22: -65.2M Q4 '22: -72.9M Q1 '23: -79.9M Q2 '23: -97M Q3 '23: -85.2M Q4 '23: -68M Q1 '24: -41.9M Q2 '24: -15.8M Q3 '24: -1M Q4 '24: 8.7M Q1 '25: -13.8M Q2 '25: -23.1M Q3 '25: -34.9M Q4 '25: -42.8M Q1 '26: -33.3M Q2 '26: -32.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-105M -70M -35M 0 35M 70M 105M Q3 '21: -29.8M Q4 '21: -31.3M Q1 '22: -51.6M Q2 '22: -44.5M Q3 '22: -53M Q4 '22: -67.1M Q1 '23: -71.7M Q2 '23: -88.8M Q3 '23: -75.5M Q4 '23: -57.5M Q1 '24: -30.8M Q2 '24: -3.1M Q3 '24: 6.1M Q4 '24: 18.2M Q1 '25: -5.1M Q2 '25: -9.5M Q3 '25: -12.2M Q4 '25: -24.2M Q1 '26: -12.8M Q2 '26: -19.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 30M 60M 90M Q3 '21: 13.9M Q4 '21: 15.8M Q1 '22: 18.7M Q2 '22: 22.7M Q3 '22: 27.1M Q4 '22: 32M Q1 '23: 36.2M Q2 '23: 39.6M Q3 '23: 42.1M Q4 '23: 45M Q1 '24: 48.7M Q2 '24: 52.2M Q3 '24: 56.4M Q4 '24: 60.2M Q1 '25: 62.7M Q2 '25: 65.8M Q3 '25: 68.9M Q4 '25: 71M Q1 '26: 75.2M Q2 '26: 81.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow TTM

-50M -25M 0 25M 50M 75M Q3 '21: -16.6M Q4 '21: -19M Q1 '22: -36.8M Q2 '22: -39.3M Q3 '22: -38.4M Q4 '22: -41.7M Q1 '23: -45.7M Q2 '23: -40.4M Q3 '23: -30.2M Q4 '23: -5.6M Q1 '24: 13M Q2 '24: 40.8M Q3 '24: 59.1M Q4 '24: 64.9M Q1 '25: 65.7M Q2 '25: 62.5M Q3 '25: 61.8M Q4 '25: 64.3M Q1 '26: 48.3M Q2 '26: 42.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q3 '21: -19.8M Q4 '21: -22.5M Q1 '22: -39.9M Q2 '22: -43M Q3 '22: -43.2M Q4 '22: -47.3M Q1 '23: -54.2M Q2 '23: -51.6M Q3 '23: -41.8M Q4 '23: -19.2M Q1 '24: -6.5M Q2 '24: 20.1M Q3 '24: 34.5M Q4 '24: 36.5M Q1 '25: 41.8M Q2 '25: 34.5M Q3 '25: 25.4M Q4 '25: 28.3M Q1 '26: 4.5M Q2 '26: -489K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q1 '20: 18.7M Q2 '20: 17.5M Q3 '20: 19.9M Q1 '21: 24.9M Q2 '21: 25.1M Q3 '21: 25.3M Q1 '22: 25.4M Q2 '22: 26.1M Q3 '22: 26.3M Q1 '23: 26.6M Q2 '23: 26.7M Q3 '23: 26.8M Q1 '24: 27.5M Q2 '24: 28.7M Q3 '24: 29.4M Q1 '25: 28.6M Q2 '25: 29.5M Q3 '25: 29.1M Q1 '26: 29.9M Q2 '26: 30.4M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q3 '21: -1.22 Q4 '21: -1.24 Q1 '22: -2.04 Q2 '22: -1.75 Q3 '22: -2.05 Q4 '22: -2.59 Q1 '23: -2.72 Q2 '23: -3.36 Q3 '23: -2.85 Q4 '23: -2.15 Q1 '24: -1.14 Q2 '24: -0.13 Q3 '24: 0.21 Q4 '24: 0.62 Q1 '25: -0.19 Q2 '25: -0.35 Q3 '25: -0.45 Q4 '25: -0.83 Q1 '26: -0.42 Q2 '26: -0.64 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.